AccessHope, LLC, a company changing the way leading-edge cancer expertise is delivered, announced that it has raised $33 million in a Series B round of funding from City of Hope, one of the largest cancer research and treatment organizations in the United States. AccessHope's next phase of growth as a stand-alone company will include product and technology development, oncology network expansion and entering new markets, such as health plans, Medicare and government organizations.